Insmed Inc. buy Guggenheim
Start price
27.02.24
/
50%
€26.80
Target price
27.02.25
€49.73
Performance (%)
181.72%
End price
28.02.25
€75.50
Summary
This prediction ended on 28.02.25 with a price of €75.50. The BUY prediction by Guggenheim for Insmed Inc. saw massive gains of 181.72%. Guggenheim has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -0.148% | -0.148% | 6.633% |
| iShares Core DAX® | 0,85 % | 1,37 % | 2,61 % |
| iShares Nasdaq 100 | -0,99 % | -3,84 % | 25,55 % |
| iShares Nikkei 225® | -1,78 % | -8,53 % | 42,81 % |
| iShares S&P 500 | 0,06 % | 0,61 % | 21,57 % |
Comments by Guggenheim for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Guggenheim from $52.00 to $54.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten